Introduction
Chemotherapy Induced Peripheral Neuropathy - Overview
Chemotherapy Induced Peripheral Neuropathy - Therapeutics Development
Chemotherapy Induced Peripheral Neuropathy - Therapeutics Assessment
Chemotherapy Induced Peripheral Neuropathy - Companies Involved in Therapeutics Development
Chemotherapy Induced Peripheral Neuropathy - Drug Profiles
Chemotherapy Induced Peripheral Neuropathy - Dormant Projects
Chemotherapy Induced Peripheral Neuropathy - Discontinued Products
Chemotherapy Induced Peripheral Neuropathy - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Chemotherapy Induced Peripheral Neuropathy, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Companies, 2021 (Contd..2)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Abalone Bio Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Achelios Therapeutics Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Algo Therapeutix SAS, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Annji Pharmaceutical Co Ltd, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Apexian Pharmaceuticals Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Aphios Corp, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Aptinyx Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Asahi Kasei Pharma Corp, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Bristol-Myers Squibb Co, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Candel Therapeutics, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by CSPC NBP Pharmaceutical Co Ltd, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Daiichi Sankyo Co Ltd, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Disarm Therapeutics Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by EA Pharma Co Ltd, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Egetis Therapeutics AB, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Enveric Biosciences Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Exodos Life Sciences Limited Partnership, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Hoba Therapeutics ApS, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Immune Pharmaceuticals Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Kineta Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Kyorin Pharmaceutical Co Ltd, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by MAKScientific LLC, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Medifron DBT Co Ltd, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Metys Pharmaceuticals AG, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Mundipharma International Ltd, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Nanjing Aimeifei Biomedical Technology Co Ltd, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by NeurExo Sciences LLC, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Neuropathix Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by NeuroTherpia Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by OliPass Corporation, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Osmol Therapeutucs Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by PharmatrophiX Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Regulonix LLC, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Resolute Pharma Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Senzer Ltd, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by SiteOne Therapeutics Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Skye Bioscience Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Sonnet BioTherapeutics Holdings Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Sova Pharmaceuticals Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Stealth BioTherapeutics Corp, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Synerkine Pharma BV, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Toray Industries Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Trevena Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by WEX Pharmaceuticals Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Winsantor Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Pipeline by Xgene Pharmaceutical Inc, 2021
Chemotherapy Induced Peripheral Neuropathy - Dormant Projects, 2021
Chemotherapy Induced Peripheral Neuropathy - Dormant Projects, 2021 (Contd..1)
Chemotherapy Induced Peripheral Neuropathy - Dormant Projects, 2021 (Contd..2)
Chemotherapy Induced Peripheral Neuropathy - Discontinued Products, 2021

List of Figures
Number of Products under Development for Chemotherapy Induced Peripheral Neuropathy, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• Abalone Bio Inc
• Achelios Therapeutics Inc
• Algo Therapeutix SAS
• Annji Pharmaceutical Co Ltd
• Apexian Pharmaceuticals Inc
• Aphios Corp
• Aptinyx Inc
• Asahi Kasei Pharma Corp
• Bristol-Myers Squibb Co
• Candel Therapeutics
• CSPC NBP Pharmaceutical Co Ltd
• Daiichi Sankyo Co Ltd
• Disarm Therapeutics Inc
• EA Pharma Co Ltd
• Egetis Therapeutics AB
• Enveric Biosciences Inc
• Exodos Life Sciences Limited Partnership
• Hoba Therapeutics ApS
• Immune Pharmaceuticals Inc
• Kineta Inc
• Kyorin Pharmaceutical Co Ltd
• MAKScientific LLC
• Medifron DBT Co Ltd
• Metys Pharmaceuticals AG
• Mundipharma International Ltd
• Nanjing Aimeifei Biomedical Technology Co Ltd
• NeurExo Sciences LLC
• Neuropathix Inc
• NeuroTherpia Inc
• OliPass Corporation
• Osmol Therapeutucs Inc
• PharmatrophiX Inc
• Regulonix LLC
• Resolute Pharma Inc
• Senzer Ltd
• SiteOne Therapeutics Inc
• Skye Bioscience Inc
• Sonnet BioTherapeutics Holdings Inc
• Sova Pharmaceuticals Inc
• Stealth BioTherapeutics Corp
• Synerkine Pharma BV
• Toray Industries Inc
• Trevena Inc
• WEX Pharmaceuticals Inc
• Winsantor Inc
• Xgene Pharmaceutical Inc